60687-786 : Roflumilast 500 ug/1 Oral Tablet


NDC: 60687-786
Labeler: American Health Packaging
Product Type: Human Prescription Drug
Drug Name:  Roflumilast
Dosage Form: Oral Tablet
Application #: ANDA208213
Rev. Date: 


NDC Package Codes:

  • 60687-786-21: 30 BLISTER PACK IN 1 CARTON (60687‑786‑21) / 1 TABLET IN 1 BLISTER PACK (60687‑786‑11)

Active Ingredients:

  • Roflumilast

Dosage Strength:

  • 500 ug/1

Pharmaceutical Classes:

  • Phosphodiesterase 4 Inhibitor [EPC]
  • Phosphodiesterase 4 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0378-1905 Roflumilast 500 ug/1 Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0904-7399 Roflumilast 500 ug/1 Oral Tablet by Major Pharmaceuticals
  • 0904-7483 Roflumilast 500 ug/1 Oral Tablet by Major Pharmaceuticals
  • 13668-476 Roflumilast 500 ug/1 Oral Tablet by Torrent Pharmaceuticals Limited
  • 31722-623 Roflumilast 500 ug/1 Oral Tablet by Camber Pharmaceuticals, Inc.
  • 31722-676 Roflumilast 250 ug/1 Oral Tablet by Camber Pharmaceuticals, Inc.
  • 42571-259 Roflumilast 500 ug/1 Oral Tablet by Micro Labs Limited
  • 42571-369 Roflumilast 250 ug/1 Oral Tablet by Micro Labs Limited
  • 43547-005 Roflumilast 500 ug/1 Oral Tablet by Solco Healthcare Us, LLC.
  • 59651-275 Roflumilast 500 ug/1 Oral Tablet by Aurobindo Pharma Limited
  • 64380-786 Roflumilast 500 ug/1 Oral Tablet by Strides Pharma Science Limited
  • 68382-624 Roflumilast 250 ug/1 Oral Tablet by Zydus Pharmaceuticals USA Inc.
  • 68382-969 Roflumilast 500 ug/1 Oral Tablet by Zydus Pharmaceuticals (Usa) Inc.
  • 70771-1673 Roflumilast 250 ug/1 Oral Tablet by Zydus Lifesciences Limited
  • 70771-1674 Roflumilast 500 ug/1 Oral Tablet by Cadila Healthcare Limited
  • 72205-200 Roflumilast 500 ug/1 Oral Tablet by Novadoz Pharmaceuticals LLC
  • 72205-201 Roflumilast 250 ug/1 Oral Tablet by Novadoz Pharmaceuticals LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 60687-786 QR Code

< Prev: 60687-783Next: 60687-788 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.